F-FMCH
To determine in vivo radiometabolism, blood samples were taken from 21 mice (eight LDLR -/-ApoB 100/100 , eight IGF-II/LDLR -/-ApoB 100/100 and five C57Bl/6N healthy controls) at sacrifice. Plasma was separated with centrifugation (2100 G, 5 min) and proteins were precipitated with acetonitrile. High performance liquid chromatography coupled with on-line radioactivity detector (Radio-HPLC) was performed with
Phenomenex Partisil 10 µm SCX, 250 x 4.6 mm column, as described in [1] .
Additional animal experiments: uptake of 18 F-FMCH in more advanced atherosclerosis and in fasting state
An additional group of older atherosclerotic mice with diabetes (IGF-II/LDLR -/-ApoB 100/100 ) that were fed with a high-fat diet of a longer duration (age 8-10 months, high-fat diet 6 months, n=9, Supplemental Table   1 ) were studied to evaluate the 18 F-FMCH uptake in more advanced stages of atherosclerosis. The mice were studied for 18 F-FMCH biodistribution, autoradiography and histology in a similar manner as the other mice in the study. The results were compared with 6-month-old IGF-II/LDLR -/-ApoB 100/100 mice and with C57BL/6N controls (where applicable).
The effects of fasting were studied in a small cohort of LDLR -/-ApoB 100/100 mice (age 6-7 months, high-fat diet 4 months, n=3, Supplemental Table 1 ). The mice were fasted for 4 hours and studied for ex vivo biodistribution and biomarkers in the plasma as described in the main article.
Immunohistochemical stainings
Aortic root sections were immunostained for macrophages (Mac-3), M1 and M2 polarization markers (iNOS and MRC-1), and CD36. For the Mac-3 staining, the paraffin sections were first de-paraffinized and rehydrated. After washes and bovine serum albumin (BSA) blocking, the sections were incubated with primary antibody (Anti-Mac-3 M3/84, 1:500, BD Pharmingen) for one hour followed by peroxidase treatment and washes. Rat-on-Mouse HRP-polymer RT 517 kit (Biocare Medical, Concord, CA, USA) was utilized according to the manufacturer's instructions, followed by chromogen (DAB, Dako K3468) and counterstaining with Mayer's hematoxylin. Consecutive sections were stained for iNOS and MRC-1. The paraffin sections were de-paraffinized, rehydrated and pre-incubated in 10 mM citric acid. After washes and BSA blocking, the primary antibody (anti-iNOS ab15323, 1:200, or anti-MRC-1 ab64693, 1:500, Abcam, Cambridge, UK) was added and incubated for one hour. Secondary antibody (Dako EnVision anti-rabbit K4003) was added and incubated for 30 min after washing and H 2 O 2 treatment. The sections were again washed, followed by the addition of chromogen and counterstaining as described above. For CD36, the protocol was similar, except for the pre-incubation, which was performed by boiling in 10 mM tris-EDTA buffer. The primary antibody was anti-CD36 ab 80978, 1:500, (Abcam). The Ki-67 stainings were performed on longitudinally cut aortic cryosections. The sections were first fixed in 10 % formalin and pre-incubated in 10 mM boiling citric acid. After washes and blocking with 5 % goat serum in 3 % BSA, the primary antibody (monoclonal rat anti-mouse clone TEC-3, M7249, 1:1000, Dako) was incubated overnight. Secondary antibody (polyclonal rabbit anti-rat E0468, 1:200, Dako) was incubated for 30 minutes after washes and H 2 O 2 treatment, followed by tertiary antibody (EnVision anti-rabbit, K4003, Dako). The detection and counterstaining was performed similarly as described above.
Plasma biomarker measurements
Phospholipids were analyzed using the Phospholipids B kit (Wako Chemicals, Neuss, Germany) or Pureauto S PL kit (Daiichi Pure Chemicals, Tokyo, Japan), triglycerides using the Triglycerides GPO-PAP kit (Roche Diagnostics, Basel, Switzerland) and total cholesterol using the Cholesterol CHOD-PAP kit (Roche Diagnostics, Basel, Switzerland). In addition, phospholipid transfer protein (PLTP) and paraoxonase-1 (PON-1) activities were measured. PLTP activity (mmol ml
) was determined with a radiometric method, as described in [2] . PON-1 activity (µmol/min) was measured with a chromogenic method [3] . 
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In vivo stability of 18 F-FMCH
Intravenously administered 18 F-FMCH showed rapid in vivo radiotracer metabolism with no differences between the mouse strains. Twenty minutes after injection, 7.9 ± 0.78 % of plasma total radioactivity originated from the intact tracer (radio-HPLC retention time 4.0 min). In the urine, 40 ± 2.4 % of the radioactivity was excreted as intact tracer. The main radioactive metabolite in mice plasma was 
Aged diabetic mice represent larger and less inflamed plaques with lower 18 F-FMCH uptake
The group of aged (8-10-month-old) IGF-II/LDLR -/-ApoB 100/100 mice showed larger atherosclerotic plaques as compared with the 6-month-old mice of the same genotype (Supplemental Figure 2 and Supplemental Table 1 ). All of the older IGF-II/LDLR -/-ApoB 100/100 mice showed calcified areas in plaques. The intima-tomedia ratio was significantly higher (4.3 ± 0.49, p<0.001), whereas the percentages of Mac-3, iNOS and MRC-1 staining in plaques were lower than in the 6-month-old IGF-II/LDLR -/-ApoB 100/100 mice (11 ± 0.55, p=0.011; 8.0 ± 0.23, p=0.006; 23 ± 2.4, p=0.026, respectively). The 18 F-FMCH whole-body distribution in the aged mice (Supplemental Table 2 ) was very similar to the 6-month-old mice of the same genotype ( Table 3 in the main article). The only significant difference was observed in the lung uptake, which was lower in the aged mice (9.4 ± 1.1 vs. 13 ± 1.0 %IA/g, p= 0.031). The aortic uptake of aged IGF-II/LDLR -/-ApoB 100/100 mice was 1.7 ± 0.21 %IA/g, and aorta-to-blood ratio 3.8 ± 0.79 (difference to controls or 6-month-old mice of the same strain was not significant). In the autoradiography analysis, the plaque uptake was 170 ± 15 PSL/mm 2 and plaque-to-wall ratio was 2.2 ± 0.088, which both were significantly lower than the corresponding values in the 6-month-old age group (p=0.032 and p=0.0014, respectively).
Fasting has no significant effect on 18
F-FMCH uptake or plasma markers
The mice that fasted for 4 hours before 18 F-FMCH injection showed very similar characteristics as the nonfasted mice of the same strain (Supplemental Table 1 and Table 1 of the main article). There were no differences in 18 F-FMCH uptake between different tissues (Supplemental Table 2 and Table 3 of the main article) or in the measured markers in the plasma, except for a subtle change in PLTP activity (Supplemental Table 3 ).
Lipoprotein fraction measurements
The lipoprotein distributions were determined from pooled plasma samples in IGF mice. The high-density lipoprotein (HDL) associated cholesterol levels had no differences between strains, whereas the HDL-associated phospholipid levels tended to be lower in the IGF-II/LDLR -/-ApoB 100/100 mice.
The differences, however, were modest and measured from only one pool of plasma from each strain, so no direct conclusions can be made. No statistically significant differences were observed between fasted and non-fasted mice (results in the main article).
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F-FMCH uptake in lungs was lower in aged IGF-II/LDLR -/-ApoB 100/100 mice as compared to 6-month old mice of the same strain (results in the main article). NA=not analyzed. 
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